Increased mortality after successful treatment for Hodgkin's disease

Journal of Clinical Oncology

Volumn 16, Issue 11, 1998, Pages 3592-3600

  Hudson, Melissa M ^a   Poquette, Catherine A ^a   Lee, Ji ^a   Greenwald, Carol A ^a   Shah, Amit ^a   Luo, Xiaolong ^a   Thompson, Elizabeth I ^a   Wilimas, Judith A ^a   Kun, Larry E ^a   Crist, William M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; ASPHYXIA; BREAST CANCER; CALCULATION; CANCER CONTROL; CANCER SURVIVAL; CHILD; COHORT ANALYSIS; FOLLOW UP; HEART DISEASE; HODGKIN DISEASE; HUMAN; INFORMATION PROCESSING; LYMPHANGIOGRAPHY; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SOLID TUMOR; STANDARDIZATION; STATISTICAL ANALYSIS; SURVIVAL RATE;

EID: 0031733382     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.11.3592     Document Type: Article

References (32)

1. Hunger SP, Link MP, Donaldson SS: ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. J Clin Oncol 12:2160-2166, 1994
2. Hudson MM, Greenwald C, Thompson E, et al: Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 11:100-108, 1993
3. Oberlin O: Present and future strategies in childhood Hodgkin's lymphomas. Ann Oncol 7:573-78, 1996
4. Schellong G, Bramswig JH, Hornig-Franz I: Treatment of children with Hodgkin's disease: Results of the German Pediatric Oncology Group. Ann Oncol 3:S73-76, 1992
5. 2, IIIB, and IV Hodgkin's disease in pediatric patients: A Pediatric Oncology Group study. J Clin Oncol 5:2769-2779, 1997
6. Mauch PM, Kalish LA, Marcus KC, et al: Long-term survival in Hodgkin's disease: Relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1:33-42, 1995
7. Hudson MM, Jones D, Boyett J, et al: Late mortality of long-term survivors of childhood cancer. J Clin Oncol 15:2205-2213, 1997
8. Nicholson HS, Fears TR, Byrne J: Death during adulthood in survivors of childhood and adolescent cancer. Cancer 73:3094-3102, 1994
9. Robertson CM, Hawkins MM, Kingston JE: Late deaths and survival after childhood cancer: Implications for cure. BMJ 309:162-166, 1994
10. Wolden SL, Lamborn KR, Cleary SF, et al: Second cancers following pediatric Hodgkin's disease, J Clin Oncol 16:536-544, 1998
11. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861, 1971
12. Lukes RJ, Butler JJ: The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063-1081, 1966
13. Wilimas J, Thompson E, Smith KL: Long-term results of treatment of children and adolescents with Hodgkin's disease. Cancer 46:2123-2125, 1980
14. Wilimas JA, Thompson EI: Results of therapy for Hodgkin's disease at St Jude Children's Research Hospital, in Kamps WA, Humphrey GB. Poppema S (eds): Hodgkin's Disease in Children, Boston, MA, Kluwer Academic, 1989, pp 303-305
15. Kaplan EL. Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: Analysis and examples. Br J Cancer 35:1-39, 1977
17. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748, 1959
18. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980, p 169
19. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
20. Epilog Plus; Statistical Package for Epidemiology and Clinical Trials. Version 3. Pasadena, CA, Epicenter Software, 1993
21. Ries LAG, Kosary CL, Hankey BF, et al (eds): SEER Cancer Statistics Review. 1973-1994: Tables and Graphs, National Cancer Institute, publication no. 97-2789. Bethesda, MD, National Institutes of Health, 1997.
22. Breslow NE. Day NE: Statistical Methods in Cancer Research Volume II - The Design and Analyses of Cohort Studies. Lyon, France, International Agency for Research on Cancer, 1987
23. Lehmann E: Nonparametrics: Statistical Methods Based on Ranks. San Francisco, CA, Holden-Day, 1975
24. Henry-Amar M, Somers R: Survival outcome after Hodgkin's disease: A report from the International Database on Hodgkin's Disease. Semin Oncol 17:758-768, 1990
25. Hooper WC, Holman RC, Strine TW, et al: Hodgkin's disease mortality in the United States: 1979-1988. Cancer 70:1166-1171, 1992
26. Van Rijswijk REN, Verbeek J, Clemens H, et al: Major complications and causes of death in patients treated for Hodgkin's disease. J Clin Oncol 5:1624-1633, 1987
27. Grufferman S, Delzell E: Epidemiology of Hodgkin's disease. Epidemiol Rev 6:76-106, 1981
28. Beaty O III, Hudson MM, Greenwald C, et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609, 1995
29. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second malignant neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996
30. Hancock SL, Donaldson SS, Hoppe RT: Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208-1215, 1993
31. Joensuu H: Myocardial infarction after irradiation in Hodgkin's disease: A review. Recent Res Cancer Res 130:157-173, 1993
32. Kaste SC, Hudson MM, Jones DJ, et al: Breast masses in women treated for childhood cancer: incidence and screening guidelines. Cancer 82:784-792, 1998